Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.

A bacteria-only sugar has become the Achilles’ heel that could help defeat deadly superbugs.

Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have ...

Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-based therapeutics, today announced that the first patient has been dosed in a Phase 1a/1b ...

Decisions may depend on thymoma and what type of auto-antibodies are present ...

The link between nutrition and the immune system does exist, and the state of the intestinal microbiota plays a key role in ...

How does origami-like DNA affect brain development? How do cancer-immune cell interactions prevent immune cell activity in tumors?Two breakthrough ...

Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...

These soups will not only serve as a delicious meal when you’re not feeling your best, but will simultaneously get you on the ...

CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...